Boston Scientific Stent Suit Seeks Injunctive Relief From J&J Market Entry
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's stent patent suit against Johnson & Johnson's Cordis unit follows by ten days an agreement between J&J and Guidant to co-develop balloon dilatation catheters on a rapid-exchange platform.